Bots, editor, reviewer, Administrators
13,941
edits
No edit summary |
No edit summary |
||
Line 3,232: | Line 3,232: | ||
"title" : "Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke", | "title" : "Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke", | ||
"pmid" : "18815396" | "pmid" : "18815396" | ||
}, | |||
{ | |||
"timestamp" : "2024-06-27T17:56:09Z", | |||
"briefDesignDescription" : "Levetiracetam vs. phenytoin in status epilepticus", | |||
"fulltexturl" : "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)30724-X/fulltext", | |||
"pageid" : 4086, | |||
"pdfurl" : "https://www.thelancet.com/action/showPdf?pii", | |||
"trainingLevel" : "Resident", | |||
"citation" : "Lyttle MD, <i>et al</i>. \"Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.\". <i>Lancet</i>. 2019. 393(10186):2125-2134.", | |||
"subspecialties" : "Emergency Medicine;Pediatrics;Neurology", | |||
"expansion" : "Emergency treatment with Levetiracetam or Phenytoin in convulsive Status Epilepticus in children", | |||
"statusUsableDate" : "2024-05-16", | |||
"briefResultsDescription" : "Levetiracetam is non-inferior to phenytoin", | |||
"published" : "2019-05-25", | |||
"pageName" : "EcLiPSE", | |||
"diseases" : "Status Epilepticus", | |||
"abbreviation" : "EcLiPSE", | |||
"title" : "Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.", | |||
"pmid" : "31005385" | |||
}, | }, | ||
{ | { |